Ecaterina Cristea
Overview
Explore the profile of Ecaterina Cristea including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
66
Citations
2176
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Chamie D, Bahl R, Maia J, Echavarria-Pinto M, Gafore S, Saleh A, et al.
J Soc Cardiovasc Angiogr Interv
. 2025 Jan;
3(12):102396.
PMID: 39807240
Background: The mechanistic association between the hydraulic forces generated during contrast injection and the risk of coronary injury is poorly understood. In this study, we sought to evaluate whether contrast...
2.
Kobayashi T, Secemsky E, Klein A, Faintuch S, Bulman J, Weinstein J, et al.
J Soc Cardiovasc Angiogr Interv
. 2024 Aug;
3(6):102049.
PMID: 39132596
Background: Despite advances in therapy options, pulmonary embolism (PE) continues to carry a high risk of mortality and morbidity. Currently, therapeutic options are limited with only 2 US Food and...
3.
Shah S, Tremmel J, Henry T, Smilowitz N, Prasad M, Kobayashi Y, et al.
J Soc Cardiovasc Angiogr Interv
. 2024 Aug;
3(6):102046.
PMID: 39132594
Background: Approximately 30% to 50% of patients who are referred for diagnostic coronary angiography are found to have no obstructive coronary artery disease (CAD). Ischemia and nonobstructive coronary arteries (INOCA)...
4.
Outcomes of the Novel Supreme Drug-Eluting Stent in Complex Coronary Lesions: A PIONEER III Substudy
Patel K, Lansky A, Kereiakes D, Windecker S, Cristea E, Pietras C, et al.
J Soc Cardiovasc Angiogr Interv
. 2024 Aug;
1(1):100004.
PMID: 39130138
Background: The Supreme healing-targeted drug-eluting stent (DES) is designed to promote endothelial healing to reduce stent-related adverse events. This may be particularly relevant among complex lesions that have a higher...
5.
Hussain Y, Kearney K, Abbott J, Kereiakes D, Di Mario C, Saito S, et al.
J Soc Cardiovasc Angiogr Interv
. 2024 Aug;
1(1):100011.
PMID: 39130137
Background: Coronary artery calcification increases the procedural complexity of percutaneous coronary intervention and is associated with worse outcomes, especially in women. Intravascular lithotripsy (IVL) has been demonstrated to be safe...
6.
Frampton J, Kearney K, Abbott J, Kereiakes D, Di Mario C, Saito S, et al.
J Soc Cardiovasc Angiogr Interv
. 2024 Aug;
2(6Part A):101069.
PMID: 39129889
Background: Intravascular lithotripsy (IVL) for calcified lesion preparation prior to drug-eluting stent placement has high procedural success and safety, especially in women, whereas other atheroablative approaches are associated with increased...
7.
Dolmatch B, Cabrera T, Pergola P, Balamuthusamy S, Makris A, Cooper R, et al.
Kidney Int
. 2023 Mar;
104(1):189-200.
PMID: 36990214
Use of a covered stent after percutaneous transluminal angioplasty (PTA) was compared to PTA alone for treatment of upper extremity hemodialysis patients with arteriovenous fistula (AVF) stenoses. Patients with AVF...
8.
Gitto M, Saito Y, Taoutel R, Schneider M, Papoutsidakis N, Ardito S, et al.
J Invasive Cardiol
. 2022 Jan;
34(3):E202-E209.
PMID: 35089162
Background: Although visual assessment of stenosis severity is routinely used to guide coronary revascularization, there are concerns about its accuracy, especially in women, who present a higher variability in coronary...
9.
Saito Y, Cristea E, Bouras G, Abizaid A, Lutz M, Carrie D, et al.
Catheter Cardiovasc Interv
. 2020 Feb;
97(3):431-436.
PMID: 32077590
Background: Quantitative flow ratio (QFR) has been validated as an accurate surrogate of standard wire-based fractional flow reserve. The clinical and angiographic outcomes of the Fantom sirolimus-eluting bioresorbable coronary scaffold...
10.
Saito Y, Grubman D, Cristea E, Lansky A
Cardiol Rev
. 2020 Feb;
28(4):208-212.
PMID: 32032131
Despite recent advances in drug-eluting stent (DES) technology, late adverse events remain concerns after percutaneous coronary intervention. The persistence of polymer material on DES has been suggested as a trigger...